INDIANAPOLIS, INDIANA - American pharmaceutical company, Eli Lilly and Co said on Wednesday interim trial data showed its experimental antibody treatment reduced the need for hospitalisation and emergency room visits for patients with moderate Covid-19.
Analysts expect antibody treatments could help some patients, as broad distribution of coronavirus vaccine candidates is expected to be lengthy. Of the total 302 patients treated with three different doses of LY-CoV555, five of them, or 1.7 per cent, had to be admitted to a hospital or visited a hospital emergency room, compared with 6 per cent, or 9 out of 150 on placebo, Lilly said.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
US eases China travel warning, citing Covid-19 progressWASHINGTON — The United States on Monday (Sept 14) eased its warning against travel to China, acknowledging that the nation had made progress against Covid-19 despite frequent US criticism of its pandemic role.
Source: TODAYonline - 🏆 1. / 99 Read more »
US eases China travel warning, citing COVID-19 progressThe United States on Monday eased its warning against travel to China, acknowledging that the nation had made progress against Covid-19 despite ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
US COVID-19 cases fall 15% in past week, deaths down for four weeksThe number of new cases of the novel coronavirus reported in the United States fell 15per cent last week from the previous seven days, and deaths ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Horsfield out of US Open after positive COVID-19 testSam Horsfield has withdrawn from this week's U.S. Open at Winged Foot Golf Club in New York after testing positive for COVID-19, the United States ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
BioNTech wins US$445 million German grant for COVID-19 vaccineBERLIN: German biotech firm BioNTech said on Tuesday (Sep 15) it had secured almost US$450 million in government funding to speed up work on its ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
US FDA's Hahn plans 'significant' work with AstraZeneca in COVID-19 trial inquiryThe US Food and Drug Administration said on Tuesday AstraZeneca Plc's COVID-19 vaccine trial in the United States is still on hold, and it was ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »